Plain-English translation of NCT07863011 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Alzheimer Disease research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing a medical device called HeLaXON 1X, which delivers very low doses of radiation to the whole brain, in people with mild Alzheimer's disease. Half of the participants will receive the actual treatment, and the other half will go through the same procedures but without any radiation (called a sham control), so researchers can fairly measure whether the treatment works. The study will track changes in memory and thinking skills over 12 months.
Alzheimer's disease gradually damages the brain and causes memory loss and confusion. Currently available treatments can only help some symptoms for a short time. Researchers want to see if carefully controlled, low-dose radiation might slow this damage by affecting harmful proteins that build up in the Alzheimer's brain.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to either receive the radiation treatment or the sham (pretend) procedure. The treatment group will visit the clinic twice a week for 3 weeks to receive six short sessions of low-dose radiation. Everyone โ both treatment and sham groups โ will undergo memory tests, brain imaging (MRI and special scans), blood tests, and physical exams at the start of the study and again at 6 and 12 months to measure any changes in thinking and memory.
AI-generated summary from trial data ยท Oct 22, 2026 ยท Not medical advice
South Korea